Why the study?
Are polymorphic markers I/D of the ACE gene and A1166C of the AT2R1 gene associated with chronic heart failure in Russian and Tatar patients post-myocardial infarction?
Are polymorphic markers I/D of the ACE gene and A1166C of the AT2R1 gene associated with chronic heart failure in Russian and Tatar patients post-myocardial infarction?
Genetic polymorphisms in the ACE and AT2R1 genes are associated with the risk and severity of chronic heart failure following myocardial infarction in Russian, but not Tatar, populations.
Polymerase chain reaction was used to study the association of polymorphic markers I/D of the angiotensin-converting enzyme gene (ACE) and A1166C of the angiotensin II type 1 receptor gene (AT2R1) with chronic heart failure (CHF) in Russian and Tatar patients that had had myocardial infarction. In Russian patients aged 50 years or younger that had had macrofocal myocardial infarction, the CC genotype of the A1166C polymorphic marker of gene AT2R1 was associated with an increased risk of CHF (OR = 11.36). Genotype DD and allele D of the I/D polymorphic marker of gene ACE were associated with a more severe CHF (functional class III-IV) in Russian patients (OR = 3.50 and 2.06). In Tatar patients, polymorphic markers I/D of gene ACE and A1166C of gene AT2R1 were not associated with CHF.
No takes yet. Share an insight, caveat, or question.
Губаев et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: